| [1] |
中华人民共和国卫生和计划生育委员会医政医管局，中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2017年版) [J].中华外科杂志, 2018, (4):241-258.
|
| [2] |
NCCN clinical practice guidelines in Oncology: Rectal Cancer (2018.V3) [EB/OL]. 2018-10-15]
URL
|
| [3] |
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Annals of Oncolog, 2017, 28(suppl_4), iv22-iv40.
|
| [4] |
Korean Academy of Medical Sciences. Korean clinical practice guideline for colon and rectal cancer v.1.0 [C]. Seoul: Korean Academy of Medical Sciences; 2012.
|
| [5] |
Park HJ, Cho S, Kim Y. Patterns of rectal cancer radiotherapy adopting evidence-based medicine: an analysis of the national database from 2005 to 2016 [J]. Cancer research and treatment: official journal of Korean Cancer Association, 2018, 50(3):975.
|
| [6] |
Watanabe T, Muro K, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer [J]. International Journal of Clinical Oncology, 2018, 23(1):1-34.
|
| [7] |
Moriya Y, Sugihara K, Akasu T, et al. Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer [J]. European Journal of Cancer, 1995, 31(7):1229-1232.
|
| [8] |
Akiyoshi T, Watanabe T, Miyata S, et al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? [J]. Annals of Surgery, 2012, 255(6):1129-1134.
|
| [9] |
Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage Ⅱ or stage Ⅲ lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial [J]. The Lancet Oncology, 2012, 13(6):616-621.
|
| [10] |
Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage Ⅱ/Ⅲ lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial [J]. Annals of Surgery, 2017, 266(2):201-207.
|
| [11] |
Yamaguchi T, Kinugasa Y, Shiomi A, et al. Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer [J]. Surgical Endoscopy, 2018, 2(11):4498-4505.
|
| [12] |
Park JS, Sakai Y, Simon N, et al. Long-term survival and local relapse following surgery without radiotherapy for locally advanced upper rectal cancer: an international multi-institutional study [J]. Medicine, 2016, 95(22):e2990.
|
| [13] |
Kang BM, Baek JH, Park SJ, et al. Impact of adjuvant therapy type on survival in stage II/III rectal cancer without preoperative chemoradiation: a Korean multicenter retrospective study [J]. Annals of Coloproctology, 2018, 34(3):144-151.
|
| [14] |
Appelt AL, Pløen J, Vogelius IR, et al. Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy[J]. International Journal of Radiation Oncology Biology Physics, 2013, 85(1):74-80.
|
| [15] |
An X, Lin X, Wang FH, et al. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a metaanalysis [J]. European Journal of Cancer, 2013, 49(4), 843-851.
|
| [16] |
Fernandez-Martos C, Garcia-Albeniz X, Pericay C, et al. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial [J]. Annals of Oncology, 2015, 26(8):1722-1728.
|
| [17] |
Sloothaak DA, Geijsen DE, van Leersum NJ, et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer [J]. British Journal of Surgery, 2013, 100(7):933-939.
|
| [18] |
Petrelli F, Sgroi G, Sarti E, et al. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer [J]. Annals of Surgery, 2016, 263(3):458-464.
|
| [19] |
Garcia-Aguilar J, Chow OS, Smith DD, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial [J]. The Lancet Oncology, 2015, 16(8):957-966.
|
| [20] |
Lee JH, Kim JG, Oh ST, et al. Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: a phase II multi-institutional clinical trial (KROG 11-02) [J]. Radiotherapy and Oncology, 2014, 110(1):150-154.
|
| [21] |
Deng Y, Chi P, Lan P, et al. Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial [J]. Journal of Clinical Oncology, 2016, 34(27):3300-3307.
|
| [22] |
Rödel C, Graeven U, Fietkau R, et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial [J]. The Lancet Oncology, 2015, 16(8):979-989.
|
| [23] |
Gérard JP, Azria D, Gourgou-Bourgade S, et al. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer [J]. Journal of Clinical Oncology, 2012, 30(36):4558-4565.
|
| [24] |
Allegra CJ, Yothers G, O′Connell MJ, et al. Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer [J]. Journal of Clinical Oncology 2014, (Suppl.15):3603
|
| [25] |
Schmoll HJ, Haustermans K, Price TJ, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Disease-free survival results at interim analysis [J]. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2014, 32(15S):Abstr 3501.
|
| [26] |
Fernández-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: grupo cáncer de recto 3 study [J]. Journal of Clinical Oncology, 2010, 28(5):859-865.
|
| [27] |
Bujko K, Wyrwicz L, Rutkowski A, et al. Long-course oxaliplatin-based preoperative chemoradiation versus 5×5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study [J]. Annals of Oncology, 2016, 27(5):834-842.
|
| [28] |
Ngan SY, Burmeister B, Fisher RJ, et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04 [J]. Journal of Clinical Oncology, 2012, 30(31):3827-3833.
|
| [29] |
Yeo SG, Oh JH, Kim DY, et al. Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01) [J]. Int J Radiat Oncol Biol Phys, 2013, 86(1):34-39.
|
| [30] |
Kim TH, Jeong SY, Choi H, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection [J]. Annals of Surgical Oncology, 2008, 15(3):729-737.
|
| [31] |
Akiyoshi T, Ueno M, Matsueda K, et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging [J]. Annals of Surgical Oncology, 2014, 21(1):189-196.
|
| [32] |
Ishihara S, Kawai K, Tanaka T, et al. Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy [J]. Diseases of the Colon & Rectum, 2017, 60(5):469-476.
|
| [33] |
Wei M, Wu Q, Fan C, et al. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial [J]. Trials, 2016, 17(1):561.
|